drugset / Trial / NCT00440739
Etoricoxib With Flavoxate for Reducing Morphine Requirement After Transurethral Prostatectomy (TURP)
RandomizedFactorialQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether etoricoxib, flavoxate, both are effective in the treatment postoperative pain after TURP. The research hypothesis: There is a difference in postoperative morphine consumption in the first 24 hours after transurethral prostatectomy between patients who received etoricoxib or flavoxate or both and placebo.
Timeline
- Start
- 2005-09
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Etoricoxib | Small molecule | 120 mg | — |
| Comparator | Flavoxate | Small molecule | 200 mg | — |
Indications
No indication recorded.